Least developed countries vs Mongolia: Immunization, measles second dose
Least developed countries
58.3%
in 2024
Mongolia
95.0%
in 2024
Least developed countries rank
35th
Mongolia rank
33rd
Immunization, measles second dose over time
- Least developed countries
- Mongolia
How they compare
Mongolia currently reports 95.0% against 58.3% in Least developed countries, a difference of 36.7%.
That makes Mongolia's figure about 1.6 times Least developed countries's.
Across all 25 years both countries report, Mongolia has been ahead every year.
Least developed countries ranks 35th and Mongolia ranks 33rd of 43 groups.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.4% | 94.6% | 93.2% | Mongolia |
| 2010s | 24.7% | 97.8% | 73.1% | Mongolia |
| 2020s | 48.7% | 94.8% | 46.1% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Least developed countries or Mongolia?
- Mongolia, at 95.0% against 58.3% in Least developed countries as of 2024.
- What is the difference in immunization, measles second dose between Least developed countries and Mongolia?
- 36.7%, with Mongolia ahead.
- How many years of comparable data are there for Least developed countries and Mongolia?
- 25 years are reported by both, from 2000 to 2024.
- How do Least developed countries and Mongolia rank globally for immunization, measles second dose?
- Least developed countries ranks 35th and Mongolia ranks 33rd of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.